JLJiwei Liu

Jiwei Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jiwei Liu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Aman Wang

    Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China

    2 shared publications
  • Baosheng Yin

    Department of Orthopaedics, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China

    1 shared publication
  • Chang Lu

    Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, 116011, Dalian, China

    1 shared publication
  • Dan Wu

    Department of Burns and Plastic Surgery, Central Hospital of Zibo, Zibo, Shandong 255036, P.R. China

    1 shared publication
  • Faisal S. Abbasi

    Department of Oncology, The First Affiliated Hospital of Dalian Medical University, 116011, Dalian, China

    1 shared publication
  • Jinxiao Liang

    Department of Thoracic Surgery, Zhejiang Cancer Hospital, 310000, Hangzhou, China

    1 shared publication

Latest Publications

  • SND1 promotes the proliferation of osteosarcoma cells by upregulating COX‑2/PGE2 expression via activation of NF‑κB

    by Ming Zhou, Aman Wang, Baosheng Yin, Dan Wu, Shiliang Han, Wenpeng Zhang, Jiwei Liu, Kang Sun

    Osteosarcoma is the most frequent primary bone tumor. Staphylococcal nuclease domain-containing 1 (SND1) is a multifunctional protein that plays important roles in tumor development and progression. Overexpression of SND1 has been found in several malignancies, however, its expression and function in osteosarcoma is largely unknown. In the present study, we firstly examined the expression of SND1 in 12 pairs of osteosarcoma and healthy bones by immunoblotting and real time-PCR. The results revealed that osteosarcoma tissues expressed significantly high SND1 mRNA and protein expression compared to normal bone tissues. Next, we stably overexpressed SND1 ORF in MG-63 cells and further defined the biological function of SND1 in osteosarcoma by flow cytometry, cell proliferation and in vivo assays. We found that SND1 overexpression significantly promoted cell proliferation and tumor growth in vitro and in vivo. Furthermore, the non-targeted metabolic profiling, ELISA and luciferase reporter assays were performed on stable overexpressing cells and blood samples to elucidate the underlying mechanisms of SND1-mediated oncogenic features. The results revealed that SND1 increased the production of arachidonic acid PGE2. The serum PGE2 expression level had a significant positive association with the SND1 mRNA expression level in osteosarcoma tissues. The SND1 overexpression-stimulated cell proliferation was enhanced by exogenous addition of PGE2. Additionally, we found that SND1 upregulated PGE2 expression through the NF-B/cyclooxygenase-2 (COX-2) pathway. In summary, our findings revealed the mechanisms of SND1 involvement in osteosarcoma tumor development, and support the targeting of SND1 as a new anti-tumor strategy for patients with osteosarcoma. In addition, SND1 may act as a potential biomarker of the therapeutic strategies utilizing COX-2 inhibitors.


  • Open Access

    Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation

    by Aman Wang, Chang Lu, Zhen Ning, Wei Gao, Yunpeng Xie, Ningning Zhang, Jinxiao Liang, Faisal S. Abbasi, Qiu Yan, Jiwei Liu

    Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation Tumor-associated macrophages promote Ezrin phosphorylation mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation